SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

BioCardia, Inc.
Date: July 14, 2025 · CIK: 0000925741 · Accession: 0000000000-25-007393

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-288592

Date
July 14, 2025
Author
Division of
Form
UPLOAD
Company
BioCardia, Inc.

Letter

Re: BioCardia, Inc. Registration Statement on Form S-3 Filed July 9, 2025 File No. 333-288592 Dear Peter Altman:

July 14, 2025

Peter Altman President and Chief Executive Officer BioCardia, Inc. 320 Soquel Way Sunnyvale, CA 94085

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Joshua Gorsky at 202-551-7836 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Austin D. March

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 July 14, 2025

Peter Altman
President and Chief Executive Officer
BioCardia, Inc.
320 Soquel Way
Sunnyvale, CA 94085

 Re: BioCardia, Inc.
 Registration Statement on Form S-3
 Filed July 9, 2025
 File No. 333-288592
Dear Peter Altman:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Joshua Gorsky at 202-551-7836 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Austin D. March
</TEXT>
</DOCUMENT>